SMN1 and proximal spinal muscular atrophy: Molecular diagnosis of SMA—i.e., loss of SMN1—has historically been made using a polymerase chain reaction (PCR)-based assay followed by digestion of the PCR product with specific restriction endonucleases (PCR-RFLP) [37,75].